---
# STRUCTURED METADATA (For Claude Code HTML Generation)
boc_code: "DM06"
boc_category: "BLOOD GLUCOSE MONITORS AND/OR SUPPLIES (MAIL ORDER)"
hcpcs_code: "E2103"
hcpcs_description: "Non-adjunctive, non-implanted continuous glucose monitor or receiver"
item_common_name: "Therapeutic CGM Receiver (Replaces K0554)"

# Clinical Classification
clinical_indications:
  - "Diabetes mellitus with insulin treatment OR history of problematic hypoglycemia (Under Review - High Confidence)"
  - "Problematic hypoglycemia: recurrent glucose <54mg/dL or level 3 requiring assistance (Under Review - High Confidence)"
  - "CGM prescribed per FDA indications for glycemic control improvement (Under Review - High Confidence)"
  - "Replaces standard blood glucose monitoring for treatment decisions (Under Review - High Confidence)"

icd10_primary:
  - "E10.x - Type 1 diabetes mellitus (Under Review - High Confidence)"
  - "E11.x - Type 2 diabetes mellitus (Under Review - High Confidence)"
  - "O24.x - Gestational diabetes mellitus (Under Review - High Confidence)"
  - "E16.2 - Hypoglycemia, unspecified (Under Review - High Confidence)"

# Coverage Requirements - Structured for comparison tables
medicare:
  covered: true
  prior_auth: "false (Under Review - High Confidence)"
  face_to_face: "In-person/telehealth visit within 6 months prior; every 6 months follow-up to document adherence (Under Review - High Confidence)"
  documentation_type: "SWO with WOPD"
  modifiers: ["CG"]
  frequency_limit: "Receiver covered per medical necessity; supplies via A4239 (1 month supply) (Under Review - High Confidence)"
  quantity_limit: "One receiver per coverage period; cannot bill standard BGM supplies with this device (Under Review - High Confidence)"
  special_notes: "REPLACED K0554 effective 1/1/2023. SWO with WOPD required before delivery. Must be on PDAC Product Classification List. CG modifier when all criteria met. Cannot bill standard BGM (E0607) with E2103."

medicaid_nassau:
  covered: true
  prior_auth: true
  dvs_authorization: "Prior authorizations honored through expiration (Under Review - High Confidence)"
  face_to_face: "Compliant data review visits required (Under Review - High Confidence)"
  documentation_type: "Pharmacy coverage"
  frequency_code: "Pharmacy (PDSP)"
  frequency_limit: "Once every 3 years typical for receiver (Under Review)"
  quantity_limit: "One receiver per coverage period (Under Review)"
  special_notes: "COVERED THROUGH PREFERRED DIABETIC SUPPLY PROGRAM (PHARMACY ONLY) effective 6/3/24 for Dexcom/Freestyle. NO LONGER AVAILABLE FROM DME PROVIDERS for PDSP products. Requires insulin treatment/pump, compliant data review visits. Prior authorizations honored through expiration."

medicaid_brooklyn:
  covered: true
  prior_auth: true
  dvs_authorization: "Prior authorizations honored through expiration (Under Review - High Confidence)"
  face_to_face: "Compliant data review visits required (Under Review - High Confidence)"
  documentation_type: "Pharmacy coverage"
  frequency_code: "Pharmacy (PDSP)"
  frequency_limit: "Once every 3 years typical for receiver (Under Review)"
  quantity_limit: "One receiver per coverage period (Under Review)"
  special_notes: "Same requirements as Nassau County. Pharmacy coverage only for PDSP products effective 6/3/24."

# Quick flags for filtering/searching
requires_prior_auth_any: true
requires_face_to_face_any: true
requires_specialty_eval: "false (Under Review)"
requires_resna_atp: "false (Under Review)"
discontinued: false
replaced_code: "K0554"
replacement_effective_date: "2023-01-01"

# Data Quality Tracking
data_quality:
  primary_source: "DM02, DM05, DM06.md (lines 431-442)"
  source_verified_fields: ["covered", "replaced_code", "replacement_date", "face_to_face_requirements", "modifiers", "pdsp_transition", "pharmacy_only_medicaid"]
  high_confidence_fields: ["clinical_indications", "icd10_primary", "problematic_hypoglycemia_definition", "pdsp_effective_date"]
  needs_verification: ["exact_frequency_medicaid", "requires_specialty_eval"]
  external_searches: []
  field_notes:
    replacement: "Source: 'Replaced K0554 effective 1/1/2023' - Medicare code crosswalk"
    face_to_face: "Source: 'In-person/telehealth visit within 6 months prior; every 6 months follow-up to document adherence'"
    modifiers: "Source: 'CG modifier when all criteria met'"
    pdsp_transition: "Source: 'Covered through Preferred Diabetic Supply Program (pharmacy only, effective 6/3/24 for Dexcom/Freestyle); no longer available from DME providers for PDSP products'"
    problematic_hypoglycemia: "Source: 'history of problematic hypoglycemia (recurrent <54mg/dL or level 3 requiring assistance)'"
    replaces_bgm: "Source: 'replaces standard BGM for treatment decisions' and 'cannot bill standard BGM supplies with this device'"
  last_verified: "2025-10-29"
  verified_by: "Claude Code"

# Metadata
last_updated: "2025-10-29"
source_documents: ["DM02, DM05, DM06.md"]
reviewed_by: "Claude Code"
---

# E2103 - Non-Adjunctive (Therapeutic) CGM Receiver

## Clinical Overview

**DM06 - MAIL ORDER CATEGORY:** This code is part of the MAIL ORDER blood glucose monitoring supplies category. Clinical coverage criteria are identical to DM05 (non-mail order), but supplies are delivered via mail order pharmacy or DME mail order provider. *(Under Review - High Confidence)*

E2103 is a non-adjunctive (therapeutic) continuous glucose monitor (CGM) receiver that **replaces standard blood glucose monitoring** for treatment decisions. This device continuously measures interstitial glucose levels and is used as the primary glucose monitoring method rather than supplementing fingerstick testing. It is appropriate for patients with diabetes who are insulin-treated OR have a history of problematic hypoglycemia. The device is prescribed per FDA indications for improving glycemic control. *(Under Review - High Confidence)*

**Important Code Update:** E2103 **replaced K0554 effective January 1, 2023**. Claims for K0554 submitted after 1/1/2023 are denied; suppliers must use E2103. *(Under Review - High Confidence)*

**Important NY Medicaid Update:** Dexcom and Freestyle CGMs available **ONLY through pharmacy providers (not DME)** effective June 3, 2024. *(Under Review - High Confidence)*

## Coverage Details

### Medicare Coverage Criteria

**Clinical Requirements:**
- Diabetes mellitus diagnosis
- **EITHER:** Insulin-treated **OR** history of problematic hypoglycemia
  - Problematic hypoglycemia defined as: Recurrent glucose <54mg/dL OR level 3 hypoglycemia requiring assistance
- CGM prescribed per FDA indications for glycemic control improvement
- Device on PDAC Product Classification List (requirement effective 7/1/2022)

**Documentation Requirements:**
- Standard Written Order (SWO) with Written Order Prior to Delivery (WOPD) required **before delivery**
- **In-person or telehealth visit within 6 months prior to initial order**
- **Every 6 months follow-up visits** to document adherence to CGM regimen
- Document insulin treatment OR problematic hypoglycemia history
- Proof of delivery required

**Modifiers:**
- **CG modifier** required when all CGM criteria are met

**Important Notes:**
- **Cannot bill standard blood glucose monitor (E0607) with E2103** - patient uses one or the other, not both *(Under Review - High Confidence)*
- **Cannot bill standard BGM supplies** (test strips A4253, lancets A4259) with therapeutic CGM - CGM replaces fingerstick testing *(Under Review - High Confidence)*
- Supplies are billed via **A4239** (1 month supply allowance) *(Under Review - High Confidence)*
- Face-to-face visits every 6 months are CRITICAL for ongoing coverage *(Under Review - High Confidence)*
- Must be on PDAC Product Classification List *(Under Review - High Confidence)*

### NY Medicaid (Nassau County)

**Clinical Requirements:**
- Gestational diabetes **OR** Type 1/Type 2 diabetes meeting CGM criteria
- Requires insulin treatment OR insulin pump
- Provider with diabetes experience for prescribing and monitoring
- Compliant data review visits required
- Patient able to respond to alerts

**Documentation Requirements:**
- **Available through Preferred Diabetic Supply Program (PHARMACY ONLY)** effective June 3, 2024 for Dexcom/Freestyle
- **NO LONGER AVAILABLE FROM DME PROVIDERS** for PDSP products
- Prior authorizations obtained before 6/3/24 honored through expiration date
- Requires insulin treatment/pump documentation
- Compliant data review visits documented
- Proof of patient ability to respond to CGM alerts

**Important Notes:**
- **CRITICAL:** Dexcom and Freestyle CGMs transitioned to pharmacy-only coverage effective 6/3/24 *(Under Review - High Confidence)*
- DME providers cannot supply PDSP-covered CGM products after transition date *(Under Review - High Confidence)*
- Prior authorizations from before transition honored through expiration *(Under Review - High Confidence)*
- Typical frequency: Once every 3 years for receiver *(Under Review)*
- Replaces standard BGM - cannot bill standard monitoring supplies *(Under Review - High Confidence)*

### NY Medicaid (Brooklyn)

**Coverage criteria identical to Nassau County.** All requirements, pharmacy transition, PDSP rules, and effective dates are the same.

## Prescription Checklist for Physicians

**Required Elements:**
- [ ] Patient demographics and Medicaid/Medicare ID
- [ ] Specific code: "E2103 - Non-adjunctive CGM receiver"
- [ ] ICD-10 diabetes diagnosis code
- [ ] Document insulin treatment OR problematic hypoglycemia history
- [ ] For hypoglycemia: Document recurrent <54mg/dL OR level 3 events
- [ ] Physician signature and date
- [ ] Ordering provider NPI number

**For Medicare:**
- [ ] Standard Written Order with WOPD completed **before delivery**
- [ ] CG modifier included on claim
- [ ] In-person/telehealth visit within 6 months prior documented
- [ ] Schedule every 6 months follow-up visits for adherence monitoring
- [ ] Verify device is on PDAC Product Classification List
- [ ] Do NOT order standard BGM supplies (E0607, A4253, A4259) with E2103
- [ ] Order supplies via A4239 (1 month supply allowance)

**For Medicaid:**
- [ ] Valid ICD-10 diabetes diagnosis on prescription
- [ ] **Route to PHARMACY, not DME** for Dexcom/Freestyle (effective 6/3/24)
- [ ] Document insulin treatment or insulin pump use
- [ ] Document provider has diabetes experience
- [ ] Schedule compliant data review visits
- [ ] Document patient can respond to CGM alerts
- [ ] If prior authorization from before 6/3/24: Honor through expiration

## Common Denial Reasons

1. **"Code not recognized"** (Medicare, if K0554 used after 1/1/2023) - Old code used. Fix: Use E2103 instead of K0554 for all claims after 1/1/2023. *(Under Review - High Confidence)*

2. **"Billed to DME provider"** (Medicaid, after 6/3/24) - PDSP product billed to DME. Fix: Route Dexcom/Freestyle CGMs to pharmacy providers only after 6/3/24. *(Under Review - High Confidence)*

3. **"Missing CG modifier"** (Medicare) - CG modifier not included. Fix: Always include CG modifier when billing CGM equipment/supplies. *(Under Review - High Confidence)*

4. **"6-month visit not documented"** (Medicare) - Missing required face-to-face visit. Fix: Document initial visit within 6 months prior and schedule ongoing 6-month visits. *(Under Review - High Confidence)*

5. **"Criteria not met"** - Patient not insulin-treated AND no problematic hypoglycemia history. Fix: Document either insulin treatment OR hypoglycemia history (recurrent <54mg/dL or level 3). *(Under Review - High Confidence)*

6. **"WOPD not obtained"** (Medicare) - Device delivered before order received. Fix: Obtain complete order BEFORE delivery. *(Under Review - High Confidence)*

7. **"Not on PDAC list"** (Medicare) - Device not on Product Classification List. Fix: Verify device is PDAC-listed before ordering. *(Under Review - High Confidence)*

8. **"Standard BGM supplies billed"** - E0607, A4253, or A4259 billed with E2103. Fix: Cannot bill standard BGM supplies with therapeutic CGM - CGM replaces fingerstick testing. *(Under Review - High Confidence)*

## Tips for Approval

**Medicare:**
- Use E2103, not K0554 - code changed effective 1/1/2023 *(Under Review - High Confidence)*
- Always include CG modifier on claims *(Under Review - High Confidence)*
- Document initial face-to-face visit within 6 months before order *(Under Review - High Confidence)*
- Schedule and document ongoing 6-month follow-up visits for adherence *(Under Review - High Confidence)*
- Clearly document insulin treatment OR problematic hypoglycemia history *(Under Review - High Confidence)*
- Verify device is on PDAC Product Classification List *(Under Review - High Confidence)*
- Do NOT order standard BGM equipment/supplies with therapeutic CGM *(Under Review - High Confidence)*
- Order CGM supplies via A4239 (1 month supply allowance), not standard test strips *(Under Review - High Confidence)*

**Medicaid:**
- Route to PHARMACY, not DME, for Dexcom/Freestyle effective 6/3/24 *(Under Review - High Confidence)*
- If prior authorization from before 6/3/24, honor through expiration *(Under Review - High Confidence)*
- Document insulin treatment or insulin pump use *(Under Review - High Confidence)*
- Prescriber should have diabetes management experience *(Under Review - High Confidence)*
- Schedule compliant data review visits with provider *(Under Review - High Confidence)*
- Document patient can respond to CGM alerts (critical safety requirement) *(Under Review - High Confidence)*
- Do NOT bill standard BGM supplies with therapeutic CGM *(Under Review - High Confidence)*

## Related Codes

- **A4239** - Supply allowance for non-adjunctive (therapeutic) CGM, 1 month - **Use this code for CGM supplies**, not standard test strips. Maximum 3 units per 90 days (Medicare). *(Under Review - High Confidence)*

- **K0554** - **DISCONTINUED 1/1/2023** - Old code for therapeutic CGM receiver. Medicare crosswalked to E2103. Use E2103 for all claims after 1/1/2023. *(Under Review - High Confidence)*

- **K0553** - **DISCONTINUED 1/1/2023** - Old code for therapeutic CGM supplies. Medicare crosswalked to A4239. *(Under Review - High Confidence)*

- **E0607** - Home blood glucose monitor (standard) - **Cannot bill with E2103**. Patient uses either standard BGM or therapeutic CGM, not both. *(Under Review - High Confidence)*

- **A4253/A4259** - Test strips/lancets - **Cannot bill with E2103**. Therapeutic CGM replaces fingerstick testing. *(Under Review - High Confidence)*

- **E2102** - Adjunctive CGM receiver - For use WITH insulin pump; does NOT replace standard BGM. Different coverage criteria than E2103. *(Under Review - High Confidence)*

- **A4238** - Supply allowance for adjunctive CGM - For adjunctive CGM (E2102), not therapeutic CGM (E2103). *(Under Review - High Confidence)*

## References

- Medicare LCD for Continuous Glucose Monitors
- Medicare Code Crosswalk K0554 â†’ E2103 (effective 1/1/2023)
- NY Medicaid Preferred Diabetic Supply Program (PDSP)
- NY Medicaid CGM Transition to Pharmacy (effective 6/3/2024)
- PDAC Product Classification List
- Source document: DM02, DM05, DM06.md (lines 431-442)
